GSK1940029 - 10mM in DMSO , CAS No.1150701-66-8

CAS: 1150701-66-8 Cat. No.: G654585 Molecular Weight: 391.25 PubChem CID: 42603008

GRADE & PURITY 10mM in DMSO

Storage

Store at -80°C

Shipped In

Dry ice packs + Cold packs

Overview

GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase ( SCD ) inhibitor extracted from patent WO/2009060053 A1, compound example 16.

In Vitro

GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD), which can be used to treat and/or preventing various diseases, including those mediated by SCD enzyme, such as diseases related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, skin disorders such as acne, diseases or conditions related to cancer and the treatment of symptoms linked to the production of the amyloid plaque-forming Aβ42 peptide such as Alzheimer's disease. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

IC50& Target:Stearoyl-CoA Desaturase (SCD)

Specifications

Specifications & Purity

10mM in DMSO

Biochemical and Physiological Mechanisms

GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase ( SCD ) inhibitor extracted from patent WO/2009060053 A1, compound example 16.

Storage

Store at -80°C

Shipped In

Dry ice packs + Cold packs

This product requires cold chain shipping. Ground and other economy services are not available.

Names and Identifiers

• Isomeric SMILES: CC1=C(N=NN1CC2=CC(=C(C=C2)Cl)Cl)C(=O)NC3=CC=C(C=C3)CO
• PubChem CID: 42603008
• MeSH Entry Terms: 1-(3,4-dichlorobenzyl)-N-(4-(hydroxymethyl)phenyl)-5-methyl-1H-1,2,3-triazole-4-carboxamide;1H-1,2,3-triazole-4-carboxamide, 1-((3,4-dichlorophenyl)methyl)-N-(4-(hydroxymethyl)phenyl)-5-methyl-;GSK1940029
• Molecular Weight: 391.25